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Patterns of HIV testing, drug use,
and sexual behaviors in people who use drugs:
findings from a community‑based outreach
program in Phnom Penh, Cambodia
Gitau Mburu1, Chanrith Ngin2, Sovannary Tuot2, Pheak Chhoun2, Khuondyla Pal2 and Siyan Yi2,3*

Abstract
Background: People who use drugs are an important priority for HIV programs. However, data related to their utilization of HIV services are limited. This paper reports patterns of HIV testing, drug use, and risk and service perception
among people who use drugs. Study participants were receiving HIV and harm reduction services from a communitybased program in Phnom Penh, comprised of itinerant peer-led outreach and static drop-in centers.
Methods: This was a mixed-methods study conducted in 2014, comprising of a quantitative survey using a structured questionnaire, followed by two focus group discussions among a sub-sample of survey participants. Participants
were recruited from hotspots in five HIV high-burden communes using a two-stage cluster sampling method. Quantitative descriptive analyses and qualitative thematic analyses were performed.
Results: This study included 151 people who use drugs with a mean age of 31.2 (SD = 6.5) years; 77.5% were male
and 39.1% were married. The most common drugs used were methamphetamines (72.8%) and heroin (39.7%), and
38.0% injected drugs in the past 3 months. Overall, 83.3% had been tested for HIV in the past 6 months, of whom
62.5% had been tested by peers through community-based outreach. However, there were ongoing HIV risks: 37.3%
were engaging in sex on drugs, only 35.6% used a condom at last sexual intercourse, and 10.8% had had a sexually
transmitted infection in the last 6 months. Among people who reported injecting drugs in the past 3 months, 27.5%
reported re-using needles/syringes. Almost half (46.5%) perceived themselves as being at lower risk of HIV compared
to the general population. Qualitative results contextualized the findings of low perception of HIV risks and suggested
that although services were often unavailable on weekends, at night, or during national holidays, peer-led community-based outreach was highly accepted.
Conclusions: A peer-led community-based approach was effective in reaching people who use drugs with HIV and
harm reduction interventions. To mitigate ongoing HIV risks, expanding access to combination prevention interventions and implementing strategies to enable people who use drugs to objectively assess their HIV risks are required.
Additionally, community-based programs should collect data along the care continuum, to enable decentralized
tracking of progress towards 90–90–90 goals at local levels.
Keywords: 90–90–90 targets, HIV testing, HIV risk, People who use drugs, People who inject drugs, Cambodia
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Background
Prompt HIV diagnosis, timely linkage to care, early treatment, retention in care, and sustained viral suppression are all essential for optimal impact of antiretroviral
therapy (ART) in reducing morbidity and mortality from
human immunodeficiency virus (HIV) [1–4]. The timesensitive sequencing of clinical and operational events
that commence with an HIV diagnosis and end with long
term viral suppression epitomize the continuum of HIV
care [5].
However, significant loss to follow-up of people living
with HIV occurs in the various steps between HIV testing and viral suppression [6, 7], resulting in an undesirable cascade [5]. Hence, a paradigm shift focusing on
proportions of people living with HIV that are tested,
linked to care, retained in care, adherent to ART, and
achieving sustained viral suppression is increasingly
framing outcomes of HIV care. The UNAIDS 90–90–90
targets, which aim to ensure that 90% of all people living with HIV know their status, 90% of all diagnosed people living with HIV receive ART, and 90% of all persons
receiving ART achieve viral suppression [8], capture this
paradigm shift.
Achievement of these global goals will depend on their
attainment among all people living with HIV and key
populations including people who use drugs [9]. People who use drugs constitute one of the most vulnerable
populations to HIV. Unsafe drug use accounts for a third
of newly diagnosed HIV infections outside sub-Saharan
Africa [10], and 10% of all HIV infections globally [11].
Drug use is particularly widespread in Asia [12], and its
impact on HIV is increasing [13]. In Cambodia, where
the national HIV prevalence is 0.3% among the general
population, people who use drugs are disproportionately
affected, with a prevalence of 4.0% among people who
use non-injecting drugs and 24.8% among individuals
who inject them [14].
Given the importance of people who use drugs in the
global HIV epidemic, it is essential that early testing,
linkage, retention, and viral suppression are achieved
among these groups. Currently, however, very few countries are well poised to attain the 90–90–90 targets in
people who use drugs by 2020. A recent review revealed
a significant lack of data related to HIV care continuum
among people who use drugs. In the few countries where
data are available, care outcomes among people who use
drugs are significantly below 90–90–90 targets [9]. Individual studies have reported that people who use drugs
have low rates of ART coverage [15], HIV testing [9],
adherence [16], retention [17], and viral suppression [9,
17]. Although contextual differences exist, these poor
outcomes are generally caused by a range of individual,
social, legal, health system, and other structural barriers
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[13, 18, 19]. In addition, effective models for promoting
the widespread reach and entry of people who use drugs
into HIV care are generally limited globally [20].
Cambodian national response has placed an emphasis
on key populations, including people who use drugs, in
order to achieve the 90–90–90 target and eliminate new
HIV infections under Cambodia 3.0 [21]. A recent review
reported that, of the estimated 72,607 people living with
HIV, 60,336 (83%) are diagnosed, 54,769 (75%) are receiving ART, and 50,935 (70%) are virally suppressed. As
such, Cambodia is one of the few countries on track to
achieve 90–90–90 targets [22]. However, this review did
not evaluate care continuums for specific populations
(e.g., key populations), which—authors assert—would
more directly inform programming strategies for these
populations [22].
In Cambodia, there are still gaps in the data and strategic information on the HIV situation and response,
in particular among key affected populations [23]. The
national estimated number of people who use noninjecting drugs and people who inject drugs was 13,000
and 1300, respectively [14]. However, precise 90–90–90
estimates among these populations are unavailable. Like
many other countries, strategic information in each step
along the continuum for people who use drugs is limited
[14]. One of the five key objectives of the National Strategic Plan on Harm Reduction is strengthening the strategic information base [23].
In this paper, we report patterns of HIV testing, drug
use, and sexual behaviors among people who use drugs
who were receiving HIV and harm reduction services
from a community-based HIV program in Phnom Penh.
We also report their self-perception of HIV risk and
views regarding community-based services they were
receiving, in order to provide information that could
improve services for this population. We conclude this
paper with a brief discussion of the potential implications of our findings in relation to 90–90–90 targets in
Cambodia.

Methods
Study design

This was a mixed-methods study that was composed of
a large quantitative cross sectional survey, with a smaller
qualitative component comprising focus group discussions (FGDs).
Study settings

The research was conducted among people who use
drugs in Phnom Penh, who were in contact with a community-based program known as Sustainable Action
against HIV and AIDS in Communities (SAHACOM).
SAHACOM was implemented over a 5-year period
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ending in December 2014, focusing on key populations
[24, 25]. The project was implemented by KHANA,
a leading HIV non-governmental organization working through numerous community-based organizations
(CBOs).
The project utilized a community-based approach to
empower and create ownership of the project among key
populations, including people who use drugs. The model
was composed of itinerant peer-based outreach, and static
drop-in centers. Through this model, key population peers
were hired by CBOs to provide HIV and harm reduction
services to people who use drugs, including HIV education, condoms, clean needles, and syringes. Through peer
involvement, the model transformed people who currently or formerly used drugs from passive service recipients to active providers of services [26].
Besides providing the above services in their own localities, peers referred people who use drugs to the static
drop-in centers, which were part of community-level
infrastructure, where methadone, harm reduction counselling, peer discussions, personal care, needles, syringes,
and condoms, among other commodities, were provided.
In addition, people who use drugs in contact with the
outreach teams were encouraged to form and attend peer
discussions at drop-in centers for education purposes.
At the end of the implementation period, data were
collected to assist in evaluation of the project. The purpose of the evaluation was to understand the HIV testing
and prevention needs of the participants, and their perception of the SAHACOM services. Mixed methods were
used to allow contextualization of quantitative survey
data. This is a widely used approach of linking quantitative and qualitative data within implementation research
[27, 28].
Participant selection

By the time the SAHACOM was implemented, the estimated total number of people who use drugs in Phnom
Penh was 4188; of these 1068 injected drugs. In Phnom
Penh, SAHACOM was implemented in 33 communes
with high concentration of people who use drugs out of
96 communes in the city. Although accurate general population size for these communes was not available, strategic information related to HIV suggested that these 33
communes covered approximately 1969 people who use
drugs, of whom 353 injected drugs. A two-stage cluster
sampling method was used to select participants for the
quantitative component. At the first stage, the research
team identified five communes with at least 20 people who use drugs to be included in the study. A list of
‘hotspots’ where people who use drugs and congregated
was made based on geographical clustering of high risk
behaviors as is practiced elsewhere [29]. At the second
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stage, all people who use drugs in the selected hotspots
were approached and invited to participate in the study,
and were screened for eligibility.
Potential participants were included in the study if
they: (1) were at least 18 years of age, (2) had used any
form of illicit drugs in the past 3 months, (3) were able
to present themselves on the day of the interview, and (4)
were able to provide informed consent to participate in
the study. Of the 192 people screened, 22 were excluded,
leaving 170 eligible participants. For the qualitative component, a convenience-based subsample was selected
from the primary participants in the quantitative phase.
At the end of quantitative data collection, participants
were invited to take part in focus group discussions based
on interest, convenience, availability, and willingness to
consent. The participant selection process is illustrated in
Fig. 1.
Study tools development

The quantitative questionnaire was developed in English, translated into Khmer, back-translated to English,
and pretested to ensure that it was culturally suitable
and clearly understandable. Standardized questions
were adapted from previous studies and Demographic
and Health Surveys [14, 30, 31] to document participants’ socio-demographic characteristics (e.g. age, sex,
marital status, education, occupation, income, residence, and mobility), drug use characteristics (e.g. age
of initiation, frequency, method and types and circumstances of drug use, sharing of needles or syringes, as
well as history of drug-related arrests and voluntary
rehabilitation or incarceration/imprisonment), HIVrelated characteristics (e.g. prior HIV testing, venue of
HIV testing and counselling, and sources of HIV education), sexual behaviors (e.g. sexual activity, number
of sex partners, consistency of condom use, history of
STI symptoms, whether STI treatment was sought, and
nature of facility from which treatment for STI was
sought), and self-perceived risk of HIV. To get a sense
of participants’ self-perceived risk of HIV, participants
were asked to indicate whether they thought they
were at lower, same, or higher risk, relative the general
population.
Similarly, a topic guide for qualitative focus groups
was developed in English, translated into Khmer, backtranslated to English, pretested, and adjusted accordingly
following piloting. The objective of the qualitative component was to contextualize and provide insights to the
quantitative findings. The focus group topic guide questions were open ended and explored participants’ drug
use behaviors, HIV testing experiences, sexual behaviors,
perceived risk of HIV, and perception of services they
were receiving through the SAHACOM.
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Total esmated number of people
who use drugs in Phnom Penh
(n= 4,188)
Excluded:
• Did not reside in the program
coverage area (n= 2,285)
Total number of people who
use drugs in 33 communes
under SAHACOM coverage (n=
1,969)

Number of communes with ≥
20 people who use drugs and
included in sampling (n= 05)

Data analyses

Approached and screened
(n= 192)
Excluded:
• Did not fulfil eligibility
criteria (n= 22)
Completed the quantave
survey (n= 170)

Excluded in data analyses:
• Reported not using drugs in
the past 3 months (n= 19)
Included in data analyses
(n= 151)
A sub-sample parcipated in
focus groups (n= 12)

Interested and consenting participants were provided
with appointment schedules to attend the discussions.
Invitation to take part in the focus groups was not based
on types of drugs used, as long as participants had participated in the quantitative survey. In total, two focus group
sessions, each with six participants, were conducted on
the premises of CBOs. Recruitment for the focus groups
was guided by saturation of themes, rather than by prespecified sample size as recommended in qualitative
studies [32]. At the end of the second focus group session, it was clear that additional discussions would not
yield further insights and recruitment was halted. The
focus groups lasted 45–60 min, were tape-recorded, and
were conducted in the local Khmer language.

Data
presented
jointly in this
manuscript

Fig. 1 Participant selection process

Data collection

Data were collected by researchers in private rooms in
drop-in centers. Before data collection, researchers were
provided with an overview of the study objectives and
trained on the questionnaire filling techniques including
error checking, focus group facilitation, privacy assurance,
confidentiality, and data protection. Questionnaires were
administered face-to-face to 170 participants, each lasting
30–45 min. At the end of survey questionnaires, participants were invited to participate in the focus groups.

Quantitative data were coded and entered into a computer using Epi Data version 3 (Odense, Denmark). Double data entry was performed to limit errors. Logic checks
were performed, and 19 participants who reported that
they had not used any illicit drugs in the past 3 months
were excluded from the analyses. Summary of frequencies for nominal and ordinal variables was documented.
Descriptive analyses were used to compute means for
continuous variables. SPSS version 20.0 (IBM Corporation, New York, USA) was used for all data analyses.
Qualitative audio data were transcribed and transcripts
translated to English from Khmer and imported into
NVivo (QSR International). Thematic data analysis [33]
was then conducted inductively within the original aims
of the study, in order to provide context for the quantitative findings regarding sexual and injecting behaviors,
nature of services received by participants, and participants’ perception of those services. Nodes were created,
and populated with appropriately labelled codes. Codes
were populated with textual segments refined using constant comparison approach [34], and then categorized
based on similarities to generate overarching themes [32,
33]. Verbatim quotes were extracted from participants’
transcripts and displayed in the text to aid transparency
of interpretation as recommended [35]. Qualitative text
and quotes were presented alongside quantitative data
in order to contextualize or explain survey findings in an
integrated fashion [36].
Ethical considerations

This study was approved by the National Ethics Committee for Health Research (No. 082NECHR). Verbal
consent was obtained from each participant. Before
consenting, participants were informed of their right to
discontinue their participation at any time, without any
consequences. Names and contact information of the
researchers were provided to participants for use in case
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they had any questions. Identifiable data were not collected on questionnaires; instead, unique codes were utilized in order to protect confidentiality of participants.
Participant were compensated approximately US$5 for
their time and transport to participate in the study.

Results
Socio‑demographic characteristics

In total, 151 people who use drugs participated in the
survey, whose mean age was 31.2 (SD = 6.5) years; a
subsample of whom (n = 12) participated in the focus
groups. Of the total participants, 77.5% were male; 39.1%
were married, 40.4% were single, and 20.5% were either
divorced or widowed. In addition, 14.6% were unemployed, and the sample was generally non-migratory, having lived in their current locations for a mean of 19 years
(Table 1).
Drug use practices

As shown in Table 2, 38.0% of the total participants had
injected drugs in the past 3 months. On average, participants started using drugs at the age of 21.3 (SD = 6.5)
years, and had used drugs for the past 8.4 years. The most
common drugs used were amphetamines (72.8%) and
Table 1 Socio-demographic characteristics of participants
Variables

Number (%)

Mean age (years, ±SD)

31.2 ± 6.5

Gender
Male

117 (77.5)

Female

34 (22.5)

Marital status
Married

59 (39.1)

Divorced, widow

31 (20.5)

Single

61 (40.4)

Mean years of schooling completed (±SD)
Main occupation

5.2 ± 4.1

Unemployed

22 (14.6)

Laborer

33 (21.9)

Self-employed business

45 (29.8)

Office worker

10 (6.6)

Other

41 (27.2)

Monthly income (US$, ±SD)
Currently living with:

313.7 ± 601.0

Parents

41 (27.2)

Spouse/partner

60 (37.7)

Friend/colleagues

19 (12.6)

Siblings/relatives

14 (9.3)

Alone

17 (11.3)

Mean length of residency in Phnom Penh (in months,
±SD)
SD standard deviation

233.6 ± 149.3

heroin (39.7%). Although most participants used drugs
either with friends (54.4%) or alone (31.1%), a notable
proportion (14.5%) used drugs with their sexual partners.
More than half (55.3%) of the overall sample had been
referred to a rehabilitation center in their lifetime, and
21.9% had been sent to the center in the past 12 months.
A third (31.3%) had ever been incarcerated/imprisoned
due to drug possession and other offences.
Less than a third (27.5%) of participants who injected
drugs in the past 3 months reported that they had used a
needle that had been used by someone else the last time
they injected. Contextualizing this finding a participant
explained that, “we stopped sharing syringe…we try to
prevent it” (respondent # 1, focus group 1), while another
asserted that, “we take a methadone regularly, stopped
injecting and stopped sharing syringes” (respondent # 4,
focus group 1). Participants mentioned that peer educators were an important source of syringes for the participants. Besides commodity supplies, participants relied on
peer educators for “transportation service to get methadone” (respondent # 4, focus group 1).
However, participants raised concerns regarding a lack
of supplies on weekends or other days when national holidays and ceremonies were being held. One participant
asserted that, “on Saturday and Sunday, if we don’t have,
we need to buy” (respondent # 6, focus group 1), because
as explained by another participant, “they just don’t work
at weekends but Monday to Friday they come to meet
people at local” (respondent # 5, focus group 1). Participants also explained that re-using or sharing needles was
common at night when getting syringes or needles was
limited:
“Sometimes, people inject around 12 or 1 at night, so
during that time no one comes to provide you syringes or
needles” (respondent # 2, focus group 2).
Despite this gap in service provision, participants
asserted the value of outreach suggesting that, “they do
not come and provide services all the time; however, their
services reduce the cost of our expenses” (respondent # 2,
focus group 1).
HIV counselling and testing

As shown in Table 3, 96.0% had ever been tested for
HIV in lifetime, and 83.3% had received an HIV test in
the past 6 months. In addition, 97.2% had received counselling during their most recent HIV test. A majority
(62.5%) of the HIV testing was delivered through community- or peer-initiated counseling and testing, with
a minority (9.0%) having been provided through voluntary counseling and testing centers. In addition, 86.6%
had received HIV education in the past 12 months, and
although most participants received this information
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Table 2 Drug use practices among the study participants

Table 3 Access to HIV counselling, testing, and education

Variables

Variables

Number (%)

Ever tested for HIV

144 (96.0)

Tested for HIV in the past 6 months (n = 144)

120 (83.3)

Number (%)

Type of drugs used in the past 3 months
Methamphetamines

110 (72.8)

Heroin

60 (39.7)

Other (ecstasy, sniffed glue, marijuana, etc.)

5 (3.3)

Mean duration of drug use (months, ±SD)

Mean age at first time of illicit drug use (years, ±SD)
Frequency of illicit drug in the past 3 months

103.8 ± 68.7
21.3 ± 6.5

Everyday

77 (51.3)

Almost everyday

21 (14.0)

A few times a month

24 (16.0)

A few times a week

27 (18.0)

Place for last HIV testing (n = 144)

Voluntary counseling and testing center

13 (9.0)

Community/peer-initiated testing

90 (62.5)

Public health center/clinic/hospital

31 (21.5)

Private clinic/hospital

143 (99.3)

Received HIV education in the past 12 months

129 (86.6)

Received counseling for the last HIV test (n = 144)

Source of HIV education in the past 12 months (n = 129)
Mass media (television/radio/newspaper)

People with whom you used drugs the last time

10 (6.9)

Received result of the most recent HIV test (n = 144)

139 (97.2)

60 (46.2)

Alone

47 (31.1)

Poster/billboard

Friend

82 (54.4)

Peer educator or outreach worker

Sexual partner/sweetheart

22 (14.5)

Voluntary counseling and testing session

28 (21.5)

Health staff

43 (33.1)

Reason to led you try illicit drugs for the first time
I tried it by myself

45 (29.8)

Someone gave it to me or forced me to use it

6 (4.0)

Tried it with friends

81 (53.6)

Other

19 (12.6)

Injected drugs in the past 3 months

57 (38.0)

Used a used needle when injected drugs the last time
(n = 57)

14 (27.5)

Perceived that needle/syringes are easy to find (n = 57)

50 (87.7)

Self-perceived level HIV risk compared to the general
population
Higher

52 (36.1)

Same

19 (13.2)

Lower

67 (46.5)

Don’t know

6 (4.2)

HIV human immunodeficiency virus

Shared needles at last drug injection (n = 57)

8 (15.7)

Have been arrested for drug use or trafficking

70 (46.4)

Have ever been sent to a drug rehabilitation center

83 (55.3)

Have been sent to a rehabilitation center in the past 1 year 33 (21.9)
Had ever been incarcerated/imprisoned

34 (26.2)
116 (89.2)

50 (33.1)

facilities by asserting that they found outreach services
easily accessible “because they come two times per day”
(respondent # 6, focus group 2).
Sexual behaviors

Main cause of most recent incarceration/imprisonment
Drug use or possession

11 (22.4)

Drug-related crimes (e.g. theft)

31 (63.3)

Other crimes (non-drug related)

7 (14.3)

from several different sources, the most common source
of HIV education was peer educators or outreach workers (89.2%). These qualitative data suggested that community-based outreach program was an important
source of HIV education, counselling and testing which
was relatively acceptable to participants.
Contextualizing these findings, qualitative focus groups
supported the view that HIV testing and education provided by peers and outreach workers were acceptable to
participants. Referring to these peers and outreach workers, a focus group participant affirmed that, “they help us
to know that we are reactive HIV…. if we are HIV positive
we go to get ART” (respondent # 1, focus group 2). This
participant further commented that, “the organization
always comes to educate us.” (respondent # 1 focus group
2), while others contrasted access to testing in health

As shown in Table 4, 37.3% of the participants reported
having sex while intoxicated with drugs. In addition, 10.8% had been diagnosed with an STI in the past
6 months. At the same time, 41.1% reported having been
involved in sexual intercourse in the past 3 months, and
only 35.6% reported using a condom in their last sexual
intercourse act.
Table 4 Sexual behavior among the study participants
Sexual behaviors

Number (%)

Diagnosed with an STI in the past 6 months

16 (10.8)

Sought treatment for most recent STI symptom (n = 16)

2 (11.1)

Facility where the most recent STI was treated
Public health center/hospital (n = 2)

Non-governmental clinic/hospital (n = 2)

1 (50.0)
1 (50.0)

Had sexual intercourse in the past 3 months

59 (41.3)

Used condom in last sexual intercourse (n = 59)

21 (35.6)

Had sexual intercourse when intoxicated (n = 59)
STI sexually transmitted infections

22 (37.3)
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Qualitative data provided additional insights regarding the inconsistent condom use. In particular, narratives from the focus groups suggested that participants
did not believe that they needed to use condoms with
their spouses because they trusted them. Asked why they
were not using condoms, participants responded by saying that, “I trust my wife” (respondent # 6, focus group 1),
“Yes, I believe my wife” (respondent # 5, focus group 1),
among other similar responses.
HIV risk perception

As shown in Table 3, a majority of participants (56.5%)
viewed themselves to be at the same or lower risk of HIV
infection compared to the general population. Although
there were other reasons for not using condoms, such
as a “desire to have a child” (respondent # 3, focus group
1), the finding of low condom use among the sample is
relevant as it corroborates the low self-perception of
HIV risk among the participants. While responding to a
question regarding whether he thought he was at risk of
HIV, a participant stated that, “I have only my wife, I don’t
have any other partners” (respondent # 4, focus group 1),
showing that participants viewed HIV risk as external to
themselves and their drug-using behaviors.
Further exploration of this issue in the focus groups
suggested that participants believed that their increased
knowledge was contributing to their protection from
HIV, and they were no longer at high risk of HIV. When
asked whether they thought their group was a highrisk group, participants contrasted the previous lack of
knowledge with their current situation, stating that:
“Firstly, we didn’t have a support from NGOs, secondly
we don’t have a counseling from NGOs and that made
us lack knowledge about health care or prevention, so it
made us a high risk group” (respondent # 5, focus group
2).
This participant, who belonged to a specific peer discussion group of drug users in one of the drop-in centers
went on to state that:
“Now, I think my group is a low-risk group, because we
have a lot of knowledge from NGOs that come to educate us” (respondent # 5, focus group 2).
These sentiments were supported by others who
emphasized the changes in risks occurred due to the
changes in sexual and injecting behaviors, primarily due
to increased supply of harm reduction commodities. In
a typical response regarding why they thought they were
at low risk of HIV, a participant stated that, “previously,
we didn’t have condoms to use and didn’t have any NGOs
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coming to provide them” (respondent # 2, focus group 2).
Others also referred to condoms, stating that their HIV
risk was reduced “because we have NGOs who taught
about using condoms; now we know how to use it, especially to prevent STIs” (Respondent # 6, FGD 1).
Apart from availability of condoms, few participants
also referred to availability of clean syringes as giving
them a sense that they were at low risk. For instance,
one participant mentioned that, “as for now, we do not
have any disease because we use new syringes” (respondent # 1, focus group 1). As can be noted from the above
excerpts, participants felt that, apart from knowledge
per se, their use of preventive interventions was protecting them from HIV. Within these discussions, it emerged
that the use of these comodities was enhanced by their
free provision:
“Now we have NGOs to provide them, it isn’t like before
when we didn’t have and we needed to buy” (respondent
# 4, focus group 1).

Discussion
This paper describes important information regarding access to HIV testing among people who use drugs.
The study reports a high level of access to HIV testing
in the context of ongoing injecting and sexual risks, and
in a country where a quarter of people who inject drugs
(24.8%) are HIV infected [14]. The high proportion of
participants who had ever been tested (96.0%), or were
tested in the last 6 months (83.3%) is notable given the
generally low rates of testing among people who use
drugs reported from other settings [9, 37, 38].
A number of factors may have contributed to this
observation, the most likely being the model of community-based outreach, which embraced the deployment
of community support volunteers, peer facilitators, and
peer educators to provide services. The majority of those
who were tested accessed testing from these peer providers rather than voluntary counseling and testing centers.
The proportion of participants tested for HIV was high
despite the perceived low risk of HIV. This approach may
also have mitigated transport, administrative, attitudinal,
and trust-related barriers which deter testing of people
who use drugs in conventional health facilities [39, 40].
The utilization of drop-in centers and community-level
infrastructure to provide methadone, personal care, counselling and education, needles, syringes, condoms, and
other commodities may have synergistic effects on the
uptake of these HIV and harm reduction interventions.
Qualitative findings suggested that methadone was perceived as providing opportunities to reduce drug injecting, while increasing uptake of clean needles and syringes.
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These findings endorse the use of methadone to mitigate
risks [41, 42], and the use of community-based outreach
model for providing integrated HIV and harm-reduction
services [43]. Other studies have shown that the use of
socially familiar infrastructure, such as community-based
drop-in centers can act in synergy with the use of peer
counsellors or educators or outreach workers to enhance
HIV testing, entry into HIV care, and uptake of harmreduction interventions [20, 39, 44, 45].
In spite of the close contact with peer-based outreach
services, our findings highlighted ongoing risks of HIV
infection among the study sample. Study participants
believed that their knowledge of HIV and adoption of
safer injecting practices reduced their risk of HIV. While
this might be the case, participants were still exposed to
significant risks. The low perceived level of risk, combined with a low rate of condom use among those who
are sexually active, engagement in sex while intoxicated,
and the occasional sharing of needles, operate together to
escalate potential for HIV infection.
These enduring risks suggest a need for additional prevention interventions and delivery strategies tailored to
participants’ risk profile. For instance, despite the advantages of peer outreach model, a lack of outreach services
over weekends, nights, and bank holidays increased risky
injecting behaviors. While firm conclusions may not be
made about the impact of these gaps, these findings suggest a need for innovative methods such as self-dispensing
or vending machines for needles and syringes for participants who encounter these temporal shortages. On the
other hand, PrEP might be useful in situations where condom use is intended but does not occur, which is relevant
for couples, given that almost half of the participants were
in stable relationships yet condom use with spouses was
sub-optimal.
In addition, a sixth of participants used drugs with
their sexual partners, further lending weight to other calls
that testing and prevention services should be extended
to sexual partners of people who use drugs [46]. Use of
methamphetamine and other drugs during sex, colloquially termed ‘chemsex,’ is associated with higher sexual HIV
transmission risks [47, 48], and requires to be addressed
through specifically tailored information. Given the noted
disconnect between perceived risks and actual HIV risk
behaviors, further expansion of the scope of HIV education is required to enable participants objectively assess and
understand their HIV risks. For instance, models of estimating actual risks [49] could be incorporated into educational efforts.
Limitations of the study

The study involved participants who were already in
contact with peer outreach. It is therefore possible that
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this recruitment bias may have affected our results
related to participants’ uptake of HIV testing and perception towards peer-led community-based outreach.
A reason for the finding that participants held the perception that they had lower HIV risk compared to the
general population may have related to their recent HIV
testing. Moreover, the proportion of participants who
were already HIV positive was not known as participants
were not required to divulge their HIV status. Consequently, the relationship between recent test results and
risk perception could not be explored in this study. All
participants were recruited in Phnom Penh, limiting
generalizability to other people who use drugs nationally. Participants in the focus groups were selected based
on convenience, which may exacerbate this selection
bias. Despite application of eligibility criteria designed
to retain participants that were currently using drugs,
a small minority reported they had not used any form
of illicit drugs in the past 3 months. More broadly, the
methodology used in this study largely depended on participants self-reporting, and some participants skipped
some questions, which may have introduced further
limitations.
Implications for future research

Despite these limitations, our findings are consistent with
research in Cambodia and elsewhere showing the effectiveness of community-based outreach in reaching people who use drugs [20, 50]. While this study reports on
uptake of HIV testing, downstream data on linkage and
retention on ART was unavailable, yet are central in the
care continuum. Besides, the extent to which the program contributed to achievement of the first 90 in the
90–90–90 targets cannot be deduced because of lack of
denominators and prior rates of testing. This is due to
lack of local level strategic information regarding numbers of people at risk. Nationally, past efforts predominantly focused on increasing HIV testing, with significant
limited focus on the continuum on local levels [23]. This
was certainly the case in 2014 when this study was conducted [23].
However, the Health Sector Strategic Plan IV (2015–
2020) includes strategies for improving the strategic
information base as one of its cross-cutting strategy.
Generation of localized data will enable programs monitor their contributions to 90–90–90 targets better, within
their catchment areas. In addition, focus on the care
continuum is central to the relatively recent approach—
known as Boosted Continuum of Prevention to Care
and Treatment—which aims to identify and reach new
infections, ensure they are brought into care, and are
retained in ART. This approach is targeted specifically
to areas where new infections are occurring, among key
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populations, and should therefore be central to future
community-based outreach programming and research.

Conclusions
The findings of this study demonstrate that utilization
of peer outreach and community infrastructure familiar and close to people who use drugs such as drop-in
centers could contribute to increasing uptake of HIV
testing and other harm reduction interventions among
these populations. Although the uptake of testing,
needles, and syringes was high in this study, outstanding HIV risks were identified. Additional strategies are
required to ensure that people at risk are enabled to have
an objective understanding of their HIV risks and vulnerabilities of people who use drugs are mitigated in the
study context.
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